All In Biotech

Drug Trial Radar · NCT07635563

DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

Phase II, Randomized, Double-Blind, Multidose Crossover Clinical Trial to Determine the Safety and Efficacy of IHL-42X in Subjects With Obstructive Sleep Apnea

Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 120 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

120

Planned (sponsor's estimate)

Start

Jul 21, 2026

Primary completion

Apr 2027

Study completion May 2027

Sponsor

Lead sponsor
Incannex Healthcare LtdIndustry
Sponsor type
Industry
First posted
Jun 9, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Crossover
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this randomized, double-blind, multi-dose crossover clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive sleep apnea. The primary endpoint is: Change in AHI4 at the end of each treatment period compared to baseline (each treatment period is 28 days). The study will consist of three separate four-way crossover dose-comparison studies each comparing three dose strengths of IHL-42X to placebo. The double-blind four-way crossover will be conducted according to a Williams design. Each of the crossover studies will test different doses of dronabinol in combination with a distinct, set dose of acetazolamide. In total, nine different combinations of dronabinol and acetazolamide formulated as IHL-42X will be tested in the study. The optimal dose strength will be selected based on safety and efficacy over a 4-week treatment period.

Conditions

  • Obstructive Sleep Apnea (OSA)

Interventions

  • IHL-42X: 2.5 mg dronabinol + 125 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 1

  • IHL-42X: 5 mg dronabinol + 125 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 2

  • IHL-42X: 7.5 mg dronabinol + 125 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 3

  • IHL-42X: 2.5 mg dronabinol + 250 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 4

  • IHL-42X: 5 mg dronabinol + 250 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 5

  • IHL-42X: 7.5 mg dronabinol + 250 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 6

  • IHL-42X: 2.5 mg dronabinol + 375 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 7

  • IHL-42X: 5 mg dronabinol + 375 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 8

  • IHL-42X: 7.5 mg dronabinol + 375 mg acetazolamideDrug

    DReAMzz Phase 2 Investigational Product - IHL-42X Dose 9

  • Placebo: Negative controlDrug

    DReAMzz Phase 2 Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in AHI4 at the end of each treatment period compared to baselineTime frame: Each treatment period (28 days)

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Exalt Clinical Research

    Chula Vista, California · Recruiting

  • Teradan Clinical Trials LLC

    Brandon, Florida · Recruiting

  • CNS Healthcare - Jacksonville

    Jacksonville, Florida · Recruiting

  • CNS Healthcare Orlando

    Orlando, Florida · Recruiting

  • Palm Beach Research Center

    West Palm Beach, Florida · Recruiting

  • Tandem Clinical Research

    Marrero, Louisiana · Not yet recruiting

  • Velocity Clinical Research, Rockville

    Rockville, Maryland · Recruiting

  • CTI Clinical Research Center

    Cincinnati, Ohio · Recruiting

  • Intrepid Research

    Cincinnati, Ohio · Recruiting

  • Velocity Clinical Research, Anderson

    Anderson, South Carolina · Recruiting

  • CNS Healthcare - Memphis

    Memphis, Tennessee · Recruiting

  • FutureSearch Trials of Dallas

    Dallas, Texas · Recruiting

  • Sleep Therapy & Research Center

    San Antonio, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.